Literature DB >> 22194303

Phosphorylation sites in the cerebral cavernous malformations complex.

Jaehong Kim1, Nicholas E Sherman, Jay W Fox, Mark H Ginsberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22194303      PMCID： PMC3244978          DOI： 10.1242/jcs.095471

Source DB:  PubMed          Journal:  J Cell Sci        ISSN： 0021-9533            Impact factor:   5.285


× No keyword cloud information.
  33 in total

1.  Recognizing and defining true Ras binding domains I: biochemical analysis.

Authors:  Sabine Wohlgemuth; Christina Kiel; Astrid Krämer; Luis Serrano; Fred Wittinghofer; Christian Herrmann
Journal:  J Mol Biol       Date:  2005-05-06       Impact factor: 5.469

2.  Calcium/calmodulin-dependent protein kinase II controls integrin alpha5beta1-mediated cell adhesion through the integrin cytoplasmic domain associated protein-1alpha.

Authors:  D Bouvard; M R Block
Journal:  Biochem Biophys Res Commun       Date:  1998-11-09       Impact factor: 3.575

3.  Truncating mutations in CCM1, encoding KRIT1, cause hereditary cavernous angiomas.

Authors:  S Laberge-le Couteulx; H H Jung; P Labauge; J P Houtteville; C Lescoat; M Cecillon; E Marechal; A Joutel; J F Bach; E Tournier-Lasserve
Journal:  Nat Genet       Date:  1999-10       Impact factor: 38.330

4.  Mutations in apoptosis-related gene, PDCD10, cause cerebral cavernous malformation 3.

Authors:  Bulent Guclu; Ali K Ozturk; Katie L Pricola; Kaya Bilguvar; Dana Shin; Brian J O'Roak; Murat Gunel
Journal:  Neurosurgery       Date:  2005-11       Impact factor: 4.654

5.  Association of Krev-1/rap1a with Krit1, a novel ankyrin repeat-containing protein encoded by a gene mapping to 7q21-22.

Authors:  I Serebriiskii; J Estojak; G Sonoda; J R Testa; E A Golemis
Journal:  Oncogene       Date:  1997-08-28       Impact factor: 9.867

6.  Human NRAGE disrupts E-cadherin/beta-catenin regulated homotypic cell-cell adhesion.

Authors:  Bin Xue; Chuanjun Wen; Yihuan Shi; Donghong Zhao; Chaojun Li
Journal:  Biochem Biophys Res Commun       Date:  2005-10-14       Impact factor: 3.575

7.  CCM1 and CCM2 protein interactions in cell signaling: implications for cerebral cavernous malformations pathogenesis.

Authors:  Jon S Zawistowski; Lisa Stalheim; Mark T Uhlik; Amy N Abell; Brooke B Ancrile; Gary L Johnson; Douglas A Marchuk
Journal:  Hum Mol Genet       Date:  2005-07-21       Impact factor: 6.150

8.  Ccm1 is required for arterial morphogenesis: implications for the etiology of human cavernous malformations.

Authors:  Kevin J Whitehead; Nicholas W Plummer; Jennifer A Adams; Douglas A Marchuk; Dean Y Li
Journal:  Development       Date:  2004-03       Impact factor: 6.868

9.  Mutations within the MGC4607 gene cause cerebral cavernous malformations.

Authors:  C Denier; S Goutagny; P Labauge; V Krivosic; M Arnoult; A Cousin; A L Benabid; J Comoy; P Frerebeau; B Gilbert; J P Houtteville; M Jan; F Lapierre; H Loiseau; P Menei; P Mercier; J J Moreau; A Nivelon-Chevallier; F Parker; A M Redondo; J M Scarabin; M Tremoulet; M Zerah; J Maciazek; E Tournier-Lasserve
Journal:  Am J Hum Genet       Date:  2004-01-22       Impact factor: 11.025

10.  Mutations within the programmed cell death 10 gene cause cerebral cavernous malformations.

Authors:  F Bergametti; C Denier; P Labauge; M Arnoult; S Boetto; M Clanet; P Coubes; B Echenne; R Ibrahim; B Irthum; G Jacquet; M Lonjon; J J Moreau; J P Neau; F Parker; M Tremoulet; E Tournier-Lasserve
Journal:  Am J Hum Genet       Date:  2004-11-12       Impact factor: 11.025
View more
  8 in total

1.  Calcium and calmodulin-dependent serine/threonine protein kinase type II (CaMKII)-mediated intramolecular opening of integrin cytoplasmic domain-associated protein-1 (ICAP-1α) negatively regulates β1 integrins.

Authors:  Angélique Millon-Frémillon; Molly Brunner; Nadia Abed; Elodie Collomb; Anne-Sophie Ribba; Marc R Block; Corinne Albigès-Rizo; Daniel Bouvard
Journal:  J Biol Chem       Date:  2013-05-28       Impact factor: 5.157

2.  Serine phosphorylation of the small phosphoprotein ICAP1 inhibits its nuclear accumulation.

Authors:  Valerie L Su; Bertrand Simon; Kyle M Draheim; David A Calderwood
Journal:  J Biol Chem       Date:  2020-01-31       Impact factor: 5.157

3.  Structural basis for the disruption of the cerebral cavernous malformations 2 (CCM2) interaction with Krev interaction trapped 1 (KRIT1) by disease-associated mutations.

Authors:  Oriana S Fisher; Weizhi Liu; Rong Zhang; Amy L Stiegler; Sondhya Ghedia; James L Weber; Titus J Boggon
Journal:  J Biol Chem       Date:  2014-12-18       Impact factor: 5.157

4.  STK25 protein mediates TrkA and CCM2 protein-dependent death in pediatric tumor cells of neural origin.

Authors:  Barbara Costa; Michelle J Kean; Volker Ast; James D R Knight; Alice Mett; Zehava Levy; Derek F Ceccarelli; Beatriz Gonzalez Badillo; Roland Eils; Rainer König; Anne-Claude Gingras; Mike Fainzilber
Journal:  J Biol Chem       Date:  2012-07-10       Impact factor: 5.157

5.  ccm2-like is required for cardiovascular development as a novel component of the Heg-CCM pathway.

Authors:  Jonathan N Rosen; Vanessa M Sogah; Lillian Y Ye; John D Mably
Journal:  Dev Biol       Date:  2013-01-15       Impact factor: 3.582

6.  Mechanism for KRIT1 release of ICAP1-mediated suppression of integrin activation.

Authors:  Weizhi Liu; Kyle M Draheim; Rong Zhang; David A Calderwood; Titus J Boggon
Journal:  Mol Cell       Date:  2013-01-11       Impact factor: 17.970

Review 7.  Introduction to cerebral cavernous malformation: a brief review.

Authors:  Jaehong Kim
Journal:  BMB Rep       Date:  2016-05       Impact factor: 4.778

8.  Mutation prevalence of cerebral cavernous malformation genes in Spanish patients.

Authors:  Rufino Mondéjar; Francisca Solano; Rocío Rubio; Mercedes Delgado; Angel Pérez-Sempere; Antonio González-Meneses; Teresa Vendrell; Guillermo Izquierdo; Amalia Martinez-Mir; Miguel Lucas
Journal:  PLoS One       Date:  2014-01-23       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.